Cronos Group (TSE:CRON) Price Target Raised to C$6.00

Cronos Group (TSE:CRON) had its target price lifted by TD from C$5.50 to C$6.00 in a research report released on Monday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

Cronos Group Stock Up 3.0%

CRON stock opened at C$4.43 on Monday. The business’s 50-day moving average price is C$3.94 and its 200-day moving average price is C$3.73. The stock has a market cap of C$1.63 billion, a P/E ratio of 23.32, a PEG ratio of 0.12 and a beta of 1.13. The company has a quick ratio of 24.01, a current ratio of 16.18 and a debt-to-equity ratio of 0.12. Cronos Group has a twelve month low of C$3.23 and a twelve month high of C$4.66.

Cronos Group (TSE:CRON) last released its earnings results on Monday, May 11th. The company reported C$0.06 earnings per share (EPS) for the quarter. Cronos Group had a net margin of 38.95% and a return on equity of 6.46%. The company had revenue of C$62.86 million during the quarter. On average, equities research analysts forecast that Cronos Group will post -0.26 EPS for the current year.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.